Betaferon Safety Trial (BEST) Study Group[Corporate Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2001	2
2002	1
2025	0

Page 1

Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS.

Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, Zaffaroni M; Betaferon Safety Trial (BEST) Study Group. Durelli L, et al. Neurology. 2001 Oct 23;57(8):1363-70. doi: 10.1212/wnl.57.8.1363. Neurology. 2001. PMID: 11673572 Clinical Trial.

Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study.

Durelli L, Oggero A, Verdun E, Isoardo GL, Barbero P, Bergamasco B, Brossa PC, Ghigo E, Maccario M, Faggiano F; Betaferon Safety Trial (BEST) Study Group. Durelli L, et al. J Neurol Sci. 2001 Dec 15;193(1):17-22. doi: 10.1016/s0022-510x(01)00637-2. J Neurol Sci. 2001. PMID: 11718745

Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?

Verdun E, Isoardo G, Oggero A, Ferrero B, Ghezzi A, Montanari E, Zaffaroni M, Durelli L; Betaferon Safety Trial (BEST) Study Group. Verdun E, et al. J Interferon Cytokine Res. 2002 Feb;22(2):245-55. doi: 10.1089/107999002753536220. J Interferon Cytokine Res. 2002. PMID: 11911808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year